Section E · FY 2026

New Technology Section Guidelines

E New Technology Section Guidelines #

E1.a General guidelines #

Section X codes fully represent the specific procedure described in the code title, and do not require additional codes from other sections of ICD-10-PCS. When section X contains a code title which fully describes a specific new technology procedure, and it is the only procedure performed, only the section X code is reported for the procedure. There is no need to report an additional code in another section of ICD-10-PCS.

Example: XW033CA, Introduction of zanidatamab antineoplastic into peripheral vein, percutaneous approach, new technology group 10, should be assigned to indicate that zanidatamab antineoplastic was administered via a peripheral vein. A separate code from table 3E0 in the Administration section of ICD-10-PCS is not assigned in addition to this code.

E1.b #

When multiple procedures are performed, New Technology section X codes are assigned following the multiple procedures guideline.

Examples: To identify the division of aortic valve leaflets using radiofrequency energy during a valve-in-valve transcatheter aortic valve replacement (TAVR), code X28F3WB, Division of aortic valve using leaflet laceration, radiofrequency energy, percutaneous approach, new technology group 11, is assigned along with a separate code for the TAVR procedure. To identify the administration of eladocagene exuparvovec-tneq using a temporary infusion device, code XW0Q316, Introduction of eladocagene exuparvovec into cranial cavity and brain, percutaneous approach, new technology group 6, is assigned along with a separate code to identify the insertion of the temporary infusion device.

Source: ICD-10-PCS Official Guidelines for Coding and Reporting, FY 2026 from CMS, effective October 1, 2025 through September 30, 2026. We publish the guideline text as CMS wrote it and add the code links and navigation.